[Clinical significance of the so-called gastric mucous barrier].
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D004285:Dogs; D000431:Ethanol / Q000494:pharmacology; D005753:Gastric Mucosa / Q000187:drug effects / Q000502:physiology*; D005756:Gastritis / Q000209:etiology; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008094:Lithium / Q000378:metabolism; D011522:Protons; D012964:Sodium / Q000378:metabolism; D013276:Stomach Ulcer / Q000209:etiology
D011522:Protons; D000431:Ethanol; D001285:Atropine; D008094:Lithium; D012964:Sodium; D001241:Aspirin
Zur klinischen Bedeutung der sogenannten Magenschleimhautbarriere